+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

HIV screening in pregnant women: A systematic review of cost-effectiveness studies



HIV screening in pregnant women: A systematic review of cost-effectiveness studies



International Journal of Health Planning and Management 33(1): 31-50



Vertical transmission represents the major route of HIV infection for children. However, the preventive interventions available are extremely effective. This review summarizes evidence regarding the cost-effectiveness of mother-to-child-transmission preventive screenings, to help policy makers in choosing the optimal antenatal screening strategy. A systematic review following PRISMA guidelines was conducted, using 3 databases: PubMed, Scopus, and Cost-Effectiveness Analysis Registry. All articles regarding HIV screening to avoid vertical transmission were included. The review included 21 papers. Seven studies assessed the cost-effectiveness of universal antenatal screening during early gestation. Two papers considered the integration of HIV screening with other medical interventions. Eight works estimated the cost-effectiveness of HIV screening in late pregnancy. Finally, 4 papers considered the combination of multiple strategies. The selected papers focused on both developed and developing countries, with a different HIV prevalence. The characteristics and methodology of the studies were heterogeneous. However, all studies agreed about the main findings, outlining the cost-effectiveness of both universal antenatal screening and HIV rescreening in late pregnancy. Cost-effectiveness improved when HIV burden increased. The major findings were proved to be robust across various scenarios when tested in sensitivity analysis. The review confirmed the cost-effectiveness not only of HIV universal antenatal screening but also of rescreening in late gestation in both developed and developing countries. Universal screening is cost-effective even in case of extremely low HIV prevalence. Therefore, to maximize screening, coverage appears as a worldwide priority. In certain settings, a targeted screening towards high-risk groups could be a valuable option.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059805405

Download citation: RISBibTeXText

PMID: 28556453

DOI: 10.1002/hpm.2418


Related references

Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. Health Technology Assessment 4(16): I-Vi, 1-193, 2000

Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost and cost effectiveness. Bjog 109(1): 44-56, 2002

A Systematic Review of Cost-Effectiveness Analysis Studies in Newborn Screening (Nbs). Value in Health 21: S111-S112, 2018

Screening for open angle glaucoma: systematic review of cost-effectiveness studies. Journal of Glaucoma 17(3): 159-168, 2008

Systematic review of cost effectiveness in telemedicine. Quality of cost effectiveness studies in systematic reviews is problematic. BMJ 325(7364): 598, 598, 2002

Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter 18(5): 325-337, 2013

A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives. Journal of Thrombosis and Thrombolysis 44(4): 494-506, 2017

Cost-effectiveness of HIV screening for incarcerated pregnant women. Journal of Acquired Immune Deficiency Syndromes 38(2): 163-173, 2005

Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant Women. Value in Health 17(7): A509-A510, 2014

A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. Health Technology Assessment 7(4): Iii-I62, 2003

Universal HIV screening of pregnant women in England: Cost effectiveness analysis. BMJ 318(7199): 1656-1660, June 19, 1999

O2-S4.02 Cost-effectiveness of screening for Chlamydia trachomatis in Dutch pregnant women. Sexually Transmitted Infections 87(Suppl 1): A61-A62, 2011

Cost effectiveness in screening of class I HLA antibodies in Thai pregnant women. Southeast Asian Journal of Tropical Medicine and Public Health 24(Suppl. 1): 165-166, 1993

Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area. European Journal of Obstetrics & Gynecology and Reproductive Biology 37(1): 25-33, 1990

Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet 359(9321): 1919-1920, 2002